法司努單抗

維基百科,自由的百科全書
法司努單抗
單克隆抗體
種類?
目標HNGF英語Nerve growth factor
臨床資料
ATC碼
  • 未分配
識別資訊
CAS號1190239-42-9
ChemSpider
  • none
UNII
KEGG
化學資訊
化學式C6406H9896N1700O2026S46
摩爾質量144,618.27 g·mol−1

法司努單抗INN:Fasinumab)是一種人單克隆抗體,設計用於治療急性坐骨神經痛[1][2]該藥物由梯瓦製藥工業有限公司再生元製藥公司合作開發。目前正處於III期試驗(NCT03245008、NCT02683239和NCT03161093)。[3]

參考資料

  1. ^ Fasinumab (PDF). Statement On A Nonproprietary Name Adopted By The USAN Council. American Medical Association. [2023-12-06]. (原始內容存檔 (PDF)於2020-04-14). 
  2. ^ Tiseo PJ, Ren H, Mellis S. Fasinumab (REGN475), an antinerve growth factor monoclonal antibody, for the treatment of acute sciatic pain: results of a proof-of-concept study. Journal of Pain Research. 2014, 7: 523–530. PMC 4155988可免費查閱. PMID 25210473. doi:10.2147/JPR.S65974可免費查閱. 
  3. ^ Oo WM, Hunter DJ. Nerve Growth Factor (NGF) Inhibitors and Related Agents for Chronic Musculoskeletal Pain: A Comprehensive Review. BioDrugs. November 2021, 35 (6): 611–641. PMID 34807432. S2CID 244509341. doi:10.1007/s40259-021-00504-8.